Navigation Links
Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
Date:11/1/2007

at approximately $500 million. An estimated 24 million people in Japan experience insomnia, but only 7 to 8 million are currently being treated.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. The product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, endometriosis, irritable bowel syndrome, pain, and diabetes. Indiplon was licensed from DOV Pharmaceuticals in 1998. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com.

Dainnipon Sumitomo Pharma Co's Corporate Mission is to broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide. Dainippon Sumitomo Pharma Co's news releases are available through the website via the Internet at http://www.ds-pharma.co.jp/english.

In addition to historical facts, this press release may contain forward- looking statements that involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those indicated in the forward looking statements are risks and uncertainties associated with Neurocrine's business and finances and research programs in general including, but not limited to, risk and uncertainties associated with the Company's indiplon program and planned commercialization activities, risk that regulatory authorities may find our resubmission of the indiplon capsule NDA incomplete or insufficient or otherwise unapprovable or that approval may be delayed; risk that following approval of indiplon capsules, commercialization may be delayed for any of a number of reasons including market condit
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 16, 2014 Cancer Immunotherapy ... Adoptive T-cell Therapies is a new market research ... the three principal types of therapeutics that have ... in cancer immunotherapy (which is often called "immuno-oncology") ... and Adoptive cellular immunotherapy. , The regular ...
(Date:9/15/2014)... , Sept. 15, 2014  FlexTech Alliance ... for flexible, printed product demonstrators (demos) and a ... RFP process with pre-proposals due on October 22, ... Funds for proposals ultimately selected are provided by ... a significant cost share by the proposing organization. ...
(Date:9/15/2014)... fast when a patient has sepsis, a life-threatening condition ... blood -- often too fast for antibiotics to help. ... developed by a team at Harvard,s Wyss Institute for ... treat sepsis. , "Even with the best current ... at least 30 percent of the time," said Mike ...
(Date:9/15/2014)... interdisciplinary team of researchers led by Northeastern University ... precise inter-nanotube junctions and a variety of nanocarbon ... facile and easily scalable, which will allow the ... networks for use in applications ranging from electronic ... from cars to sports equipment. , Their findings ...
Breaking Biology Technology:Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 2Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 4Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 5FlexTech Alliance Issues 2015 Request for Proposals in Flexible, Printed Electronics 2Blood-cleansing biospleen device developed for sepsis therapy 2Blood-cleansing biospleen device developed for sepsis therapy 3Blood-cleansing biospleen device developed for sepsis therapy 4Northeastern University Researchers Develop Novel Method for Working with Nanotubes 2
... International,Corporation (Nasdaq: PRXL ), a leading ... as a Vice President and General,Manager in ... brings more than 20 years of experience ... position, Ms. Fisher leads a global,team of ...
... Healing ... of Chronic Wounds, ... company focused on improving patient quality of life, today,announced that ... its KFH Novo medical device, a breakthrough medical,technology that enhances ...
... a.m. ET; 8:00 a.m. PT, VANCOUVER and SAN ... MGIFF), a clinical-stage developer of drugs for infectious,diseases, will ... 13,2008 at 11:00 a.m. ET (8:00 a.m. PT) to ... 31, 2008 and provide an update on,company activities. To ...
Cached Biology Technology:PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team 2PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team 3PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team 4Kingfisher Healthcare Receives European CE Mark for Next Generation Wound Healing Device 2
(Date:9/15/2014)... outbreak in West Africa, which has claimed more than ... understanding of the molecular biology of the virus that ... antiviral drugs to treat or prevent Ebola hemorrhagic fever. ... USA under the leadership of Dr Dan Engel, ... has obtained the crystal structure of a key ...
(Date:9/15/2014)... it,s not what comes to mind when you think ... Doncaster,s 310-million-year-old past, including a fossilised shark egg case, has ... the fossilised plants and creatures may even be new to ... crabs and some previously unrecorded seed pods are amongst the ... within the coal and shale deposits in what is one ...
(Date:9/15/2014)... reports about the need for vitamin E and how ... that adequate levels of this essential micronutrient are especially ... who are or may become pregnant. , A lifelong ... said, but often complicated by the fact that this ... through diet alone. It has been estimated that only ...
Breaking Biology News(10 mins):Protein secrets of Ebola virus 2'Jaws' lived in Doncaster 2Vitamin E intake critical during 'the first 1,000 days' 2Vitamin E intake critical during 'the first 1,000 days' 3
... shrimp. Fried eggs. Burgers and fries. New research suggests ... foods are so appealing together. It has been known ... uptake, but fundamental aspects of that process remain poorly understood. ... for Science are using zebrafish to better understand the cellular ...
... People with celiac disease struggle with limited food choices, ... in wheat and other grains. Researchers from the University ... banana flour, which tasters found more acceptable than regular whole ... cheaper to produce than standard pastas. Their research is ...
... first paternity study of southern right whales has found a ... say, which is good news for the overall genetic diversity ... through in-breeding. Results of the study, by researchers at ... Zealand Department of Conservation, have just been published in the ...
Cached Biology News:Zebrafish research shows how dietary fat regulates cholesterol absorption 2Pasta made from green banana flour a tasty alternative for gluten-free diets 2First paternity study of southern right whales finds local fathers most successful 2First paternity study of southern right whales finds local fathers most successful 3
...
Request Info...
... vectors carry the kanamycin resistance gene that ... Spontaneous generation of multiple insertion events can ... of Geneticin Reagent. Pichia transformants are selected ... level of resistance to Geneticin Reagent. The ...
... Synthetic peptide derived from the C-terminal ... Math-2. Specificity: Specific for the ... (positive controls: human U251 A172 IMR-32 ... rat brain homogenates)Storage: Store at -20C ...
Biology Products: